Stay updated on Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The site’s revision/version label at the bottom of the page was updated from **v3.5.2** to **v3.5.3**, reflecting a documentation/UI release rather than a change to the clinical trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T17:13:48.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T14:09:08.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    36 days ago
    Change Detected
    Summary
    Revision: v3.5.0 has been added; Revision: v3.4.3 has been removed from the page.
    Difference
    0.1%
    Check dated 2026-03-20T00:10:11.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 on the page. This appears to be a metadata/version update with no changes to study content.
    Difference
    0.1%
    Check dated 2026-03-12T20:43:37.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:38:46.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1, and this update appears to be a version change that does not affect study data or user actions; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T22:09:18.000Z thumbnail image

Stay in the know with updates to Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Relatlimab in Metastatic Melanoma Clinical Trial page.